Department of Senological, Gynecological, Plastic and Reconstructive Surgery - Paris Professor Fabrice Lecuru - Institut Curie

Medical News

  • Facteur de risque du cancer du sein

    The most effective treatment for advanced cancers of the cervix remains concomitant radio-chemotherapy + Brachytherapy

    Mileshkin reported at the last ASCO congress, the results of the OUTBACK study. This trial compared survival after radio-chemotherapy + Brachytherapy with the same treatment followed by 4 additional cycles of chemotherapy.

    Survival was not significantly improved (overall survival and progression-free survival), but treatment toxicity was significantly worsened.

    There is therefore no reason to change our practices, apart from clinical trials. Many studies are currently testing the addition of immunotherapy or other innovative molecules to radio-chemotherapy + Brachytherapy. The COLIBRI study (addition of 2 immunotherapy molecules) is currently open at Institut Curie. Another, similar study will begin in the coming weeks.

About us

After 20 years spent at the Georges Pompidou European Hospital, I preferred to continue my activity at the Institut Curie Paris.

I joined the team of Pr Fabien REYAL (Department of Senological, Gynecological and Reconstructive Surgery)

I follow my activity of Gynecological Oncological Surgery and Recourse Surgery there.

The objective remains to provide the best possible care to women with gynecological cancers,
  - By ensuring the welcome, listening and respect for the quality of life,
  - By providing access to therapeutic innovation and clinical research.
  - Consultations take place on Wednesday afternoon and Friday morning.

Make an appointment

Choose the way you want to make an appointment with Professor Lecuru's service.

Address

Institut Curie Paris

Institutional Partners

  • Chirurgie Curie Institut Curie
  • DIU DIU Européen d'Oncologie Gynécologique et Mammaire
  • SFCO Société Française de Chirurgie Oncologique
  • IMAGYN Initiative des malades atteintes de cancers gynécologiques

Scientific Partners

IMAGYN
ONCOSTREAM
YKSI Production
TMRG
© Copyright - The site is managed in partnership with the French Institute of Gynecology. It is an information and communication tool intended for the general public, patients and health professionals in particular, in accordance with the Code of medical ethics and the recommendations of the National Council of the Order of Physicians, concerning the medical ethics on the health web, adopted in a report of May 22, 2008. The information or advice contained therein is intended to inform the FRENCH public, in simplified terms, of the current state of medical science, its pathways of research and its advances. In no case may this information or advice exonerate health professionals or patients from a real consultation with an anamnesis and a clinical examination, which alone can lead to a diagnosis and a prescription.
Haut